Skip to main content

Table 4 Matching, baseline and outcome variables for patients receiving (FBNc group) or not (comparator group) FBNc

From: Administration of fibrinogen concentrate for refractory bleeding in massively transfused, non-trauma patients with coagulopathy: a retrospective study with comparator group

Variables

FBNc N = 38

Control N = 38

P value

Age (years)

62 [55, 68]

62 [57, 73]

NS

SOFA

6 [4, 8]

5.5 [4, 8]

NS

Gender (males)

26 (68.4)

31 (81.5)

NS

Haemorrhage occurring outside the OR or ICU

10 (26.3)

10 (26.3)

NS

Diagnoses

   

Cardiac surgery

21 (55.3)

21 (55.3)

 

Liver transplantation

7 (18.4)

7 (18.4)

 

Gastrointestinal bleeding

10 (26.6)

10 (26.6)

NS

Variables at beginning of bleeding

   

pH

7.30 [7.28, 7.33]

7.31 [7.26, 7.37]

NS

Base excess (mEq/L)

-4.7 [-8.0, -3.0]

-4.0 [-6.0, 0.4]

NS

Creatinine (mg/dL)

0.8 [0.7, 1.3]

0.9 [0.7, 1.4]

NS

Leucocytes (x 109/L)

7.1 [4.7,11.7]

9.7 [7.3, 15.0]

0.04

Platelets (x 109/L)

112 [72, 173]

98 [63, 144]

NS

Haemoglobin (g/L)

84.5 [72.0, 108.0]

70.0 [64.0, 75.0]

0.00

Prothrombin time (s)

18.0 [13.0, 28.0]

18.0 [14.0, 21.0]

NS

Thromboplastin time (s)

43.5 [32.4, 63.8]

47.7 [36.2, 59.2]

NS

Fibrinogen (g/L)

1.7 [0.9, 2.3]

2.0 [1.5, 3.3]

0.04

INR

1.6 [1.2, 2.5]

1.5 [1.2, 1.8]

NS

Outcome variables

   

In-hospital mortality

13 (34.2)

10 (26.3)

NS

Length of hospital stay (days)*

15 [7, 32]

22 [14, 29]

NS

PRBC (units)

8 [5, 12]

6 [5, 12]

NS

FFP (units)

2 [0, 5]

3 [0, 5]

NS

Platelet (pools)

1 [0, 2]

2 [1, 3]

NS

Total transfusion (units)

11 [6, 20]

10 [6, 16]

NS

  1. Only 76 patients were successfully pair-matched (38 pairs). (See caption for Table 1 for details).